1. Targeting the deubiquitinase USP2 for malignant tumor therapy (Review)
    Shilong Zhang et al, 2023, Oncology Reports CrossRef
  2. USP1 promotes cholangiocarcinoma progression by deubiquitinating PARP1 to prevent its proteasomal degradation
    Deng Yong Zhang et al, 2023, Cell Death & Disease CrossRef
  3. Targeting PEG10 as a novel therapeutic approach to overcome CDK4/6 inhibitor resistance in breast cancer
    Nar Bahadur Katuwal et al, 2023, Journal of Experimental & Clinical Cancer Research CrossRef
  4. ZEB1 Is Regulated by K811 Acetylation to Promote Stability, NuRD Complex Interactions, EMT, and NSCLC Metastasis
    Mabel Perez-Oquendo et al, 2023, Molecular Cancer Research CrossRef
  5. The role of USP51 in attenuating chemosensitivity of lung cancer cells to cisplatin by regulating DNA damage response
    Feng Zhou et al, 2023, Biotechnology and Applied Biochemistry CrossRef
  6. Pro-apoptotic and anti-apoptotic regulation mediated by deubiquitinating enzymes
    Hae-Seul Choi et al, 2022, Cellular and Molecular Life Sciences CrossRef
  7. Protein degradation: expanding the toolbox to restrain cancer drug resistance
    Hui Ming et al, 2023, Journal of Hematology & Oncology CrossRef
  8. The roles of protein ubiquitination in tumorigenesis and targeted drug discovery in lung cancer
    Zhen Ye et al, 2023, Frontiers in Endocrinology CrossRef
  9. Biochanin A inhibits lung adenocarcinoma progression by targeting ZEB1
    Jianjun Li et al, 2022, Discover Oncology CrossRef
  10. Regulation of ZEB1 Function and Molecular Associations in Tumor Progression and Metastasis
    Mabel Perez-Oquendo et al, 2022, Cancers CrossRef
  11. ZEB1: Catalyst of immune escape during tumor metastasis
    Jiahui Lu et al, 2022, Biomedicine & Pharmacotherapy CrossRef